FAH (fumarylacetoacetate hydrolase)

2014-11-01  

Identity

HGNC
LOCATION
15q25.1
LOCUSID
ALIAS
-
FUSION GENES

Other Information

Locus ID:

NCBI: 2184
MIM: 613871
HGNC: 3579
Ensembl: ENSG00000103876

Variants:

dbSNP: 2184
ClinVar: 2184
TCGA: ENSG00000103876
COSMIC: FAH

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000103876ENST00000261755P16930
ENSG00000103876ENST00000261755A0A384P5L6
ENSG00000103876ENST00000407106P16930
ENSG00000103876ENST00000407106A0A384P5L6
ENSG00000103876ENST00000558022H0YLC7
ENSG00000103876ENST00000561353H3BNP8
ENSG00000103876ENST00000561421P16930
ENSG00000103876ENST00000561421A0A384P5L6

Expression (GTEx)

0
10
20
30
40
50
60

Pathways

PathwaySourceExternal ID
Tyrosine metabolismKEGGko00350
Tyrosine metabolismKEGGhsa00350
Metabolic pathwaysKEGGhsa01100
Tyrosine degradation, tyrosine => homogentisateKEGGM00044
Tyrosine degradation, tyrosine => homogentisateKEGGhsa_M00044
MetabolismREACTOMER-HSA-1430728
Metabolism of amino acids and derivativesREACTOMER-HSA-71291
Phenylalanine and tyrosine catabolismREACTOMER-HSA-71182
Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolismREACTOMER-HSA-6788656

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
363699072023The compound heterozygous mutations of c.607G>a and c.657delC in the FAH gene are associated with renal damage with hereditary tyrosinemia type 1 (HT1).1
363699072023The compound heterozygous mutations of c.607G>a and c.657delC in the FAH gene are associated with renal damage with hereditary tyrosinemia type 1 (HT1).1
336701792021Therapeutic Targeting of Fumaryl Acetoacetate Hydrolase in Hereditary Tyrosinemia Type I.2
343823512021Survival-Assured Liver Injury Preconditioning (SALIC) Enables Robust Expansion of Human Hepatocytes in Fah(-/-) Rag2(-/-) IL2rg(-/-) Rats.4
346782092021Fumarylacetoacetate hydrolase gene as a knockout target for hepatic chimerism and donor liver production.3
336701792021Therapeutic Targeting of Fumaryl Acetoacetate Hydrolase in Hereditary Tyrosinemia Type I.2
343823512021Survival-Assured Liver Injury Preconditioning (SALIC) Enables Robust Expansion of Human Hepatocytes in Fah(-/-) Rag2(-/-) IL2rg(-/-) Rats.4
346782092021Fumarylacetoacetate hydrolase gene as a knockout target for hepatic chimerism and donor liver production.3
315843092020Genetic Analysis of Tyrosinemia Type 1 and Fructose-1, 6 Bisphosphatase Deficiency Affected in Pakistani Cohorts.5
332181902020E3 Ubiquitin Ligase APC/C(Cdh1) Negatively Regulates FAH Protein Stability by Promoting Its Polyubiquitination.1
315843092020Genetic Analysis of Tyrosinemia Type 1 and Fructose-1, 6 Bisphosphatase Deficiency Affected in Pakistani Cohorts.5
332181902020E3 Ubiquitin Ligase APC/C(Cdh1) Negatively Regulates FAH Protein Stability by Promoting Its Polyubiquitination.1
308432372019A liver-humanized mouse model of carbamoyl phosphate synthetase 1-deficiency.10
315687112019Mutational spectrum of Mexican patients with tyrosinemia type 1: In silico modeling and predicted pathogenic effect of a novel missense FAH variant.4
308432372019A liver-humanized mouse model of carbamoyl phosphate synthetase 1-deficiency.10

Citation

Dessen P

FAH (fumarylacetoacetate hydrolase)

Atlas Genet Cytogenet Oncol Haematol. 2014-11-01

Online version: http://atlasgeneticsoncology.org/gene/62975